PriceSensitive

Empower Clinics (CSE:CBDT) subsidiary Medisure launches Health Canada approved vitamin D testing kit

Health Care, Sponsored, The Watchlist
CSE:CBDT
27 April 2022 13:00 (EDT)

This browser does not support the video element.

Empower Clinics (CBDT) subsidiary Medisure has announced the launch of the Vitamin D Rapid Testing Kit.

Steven McAuley, Chairman and CEO of Empower Clinics sat down with Shoran Devi to discuss the news.

“The launch and pre-sales of this Vitamin D at-home testing solution is a perfect execution of our vision of being a leading integrated healthcare company.

We co-created this product in partnership with pharmacies who in turn placed advance orders. We maximized internal synergies by distributing this Medisure product to our Medi-Collective (TMC) clinics. And we are delivering on our commitment to continually offer convenient, accessible and integrated healthcare solutions – online, in our TMC clinics or in our partner pharmacies – to patients across Canada.”

The MediSure® Vitamin D Rapid Test Kits will be available at local PharmaChoice® pharmacies across the country beginning in May.

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Empower is aggressively growing its clinical and digital presence across North America.

Empower Clinics Inc. (CBDT) opened trading at C$0.125 per share.

 

Related News